Furthermore, our findings provide evidence for the role of mH2A1 in stem-like characteristics and demonstrate that novel downstream mechanisms are involved in bladder cancer progression and that more research needs to be accomplished to further quantify and identify pathways and regulators within this pathway that may lead to potential therapeutics in the treatment of bladder cancers. This evidence concerns the gene MACROH2A1 and urinary bladder carcinoma.